Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number PB2013-108837
Title Emergency Department Visits Involving Attention Deficit/Hyeractivity Disorder Stimulant Medications.
Publication Date Jan 2013
Media Count 5p
Personal Author N/A
Abstract Attention deficit/hyperactivity disorder (ADHD) is a neurobehavioral disorder marked by excessive hyperactivity, impulsivity, or inattention. Although these disorders are typically diagnosed in childhood, symptoms may persist into adulthood. About two thirds (66 percent) of children aged 4 to 17 diagnosed with ADHD took medication for the disorder in 2007, and stimulant medications remain the first-line treatment for these disorders in both children and adults. When used as directed, ADHD stimulant medications can be effective treatment, but they can also have negative side effects, such as nervousness, insomnia, dizziness, and cardiovascular or psychiatric problems. ADHD stimulant medications can also be misused to suppress appetite, enhance alertness, or cause feelings of euphoria. Past year nonmedical use of Adderall, a common ADHD stimulant medication, increased among adults from 2006 to 2010, particularly among young adults aged 18 to 25. Whether ADHD stimulant medications are misused or adverse reactions occur when the medication is taken as prescribed, monitoring dangerous health effects that require immediate medical attention can help guide intervention efforts.
Keywords Adults
Attention deficit hyperactivity disorder(ADHD)
Emergency medical services
Emergency visits
Health effects
Mental disorders

Source Agency Substance Abuse and Mental Health Services Administration
NTIS Subject Category 57T - Psychiatry
57E - Clinical Medicine
92B - Psychology
Corporate Author Substance Abuse and Mental Health Services Administration, Rockville, MD.
Document Type Technical report
Title Note N/A
NTIS Issue Number 1319
Contract Number N/A

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader